The free, impartial wellness resource connecting you to the power of choice
Are you curious about what research is happening now? Ever wondered if you could be part of a clinical trial? AHHA has set up this page to let you know what research is going on. Check out the following professionally run, holistic and integrative-related clinical trials and studies.
Title: Coconut Oil for Alzheimer’s Disease
Sponsor: University of South Florida
Medical Director: Amanda G. Smith, MD
Purpose: The goal of this randomized study is to determine the effect of taking coconut oil (Fuel For Thought™) on the cognition, functioning and behavior of older adults with mild to moderate Alzheimer’s disease.
Participant Requirements: Participants must be between 60 – 85 years old with a diagnosis of mild to moderate Alzheimer’s disease and be able to participate for a six month period.
Participant’s Receive: Participants will take Fuel For Thought™, a coconut oil fortified with medium-chain triglycerides, administered as 1.25-ounce drink, for either Months 1-3 or Months 4-6 of the study; a placebo will be taken during the other 3-month period.
Status: Currently recruiting participants.
For Further Information: www.nia.nih.gov/alzheimers/clinical-trials/coconut-oil-alzheimers-disease
Title: Lifelong feeding of cottonseed to female rats and Alzheimer’s
Sponsor: Wisconsin Institute of Nutrition Research Foundation
Study Supervision: Care Research in Colorado
Medical Director: Bruce Semon, MD, PhD
Purpose: The purpose of the study is to replicate preliminary results that long term feeding of small amounts of cottonseed cause Alzheimer’s Disease in female rats. Cottonseed, which contains toxic chemicals, is used in animal feed, and gets into the human food supply. This study is being repeated with more rats to replicate the results for publication.
Participant Requirements: This is an animal study. No human volunteers are needed.
Status: The study takes two to three years of feeding. The rats are entering their second year of eating the cottonseed.
For Further Information: email@example.com and 262-643-4222
Title:Trial to Assess Chelation Therapy
Sponsor: U.S. National Institutes of Health (National Heart, Lung, and Blood Institute/ National Center for Complementary and Alternative Medicine)
Study Supervision: Mount Sinai Medical Center, Miami Beach, FL
Medical Director: Gervasio Lamas, MD
Purpose: The major goal of the Trial to Assess Chelation Therapy is to determine whether an intensive course of disodium EDTA chelation, will reduce major adverse coronary events in patients with coronary artery disease who have recovered from a prior myocardial infarction. The primary endpoint of this trial was a composite of all cause mortality, myocardial infarction, stroke, coronary revascularization, and hospitalization for angina.
Participant Requirements: The study has completed enrollment
Participant’s Receive: Participants were randomly assigned to receive 40 infusions of either the standard disodium EDTA chelation solution or placebo.
Status: Research results have been published.
For Further Information: http://clinicaltrials.gov/ct2/show/NCT00044213